A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure
Clinical trial NCT07219849 · RECRUITING
Trial details
- NCT number
- NCT07219849
- Sponsor
- Alixer Nexgen Therapeutics Limited
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-17
- Primary completion
- 2026-04-01
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.